Michael T Byrne

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsGene and molecular therapyPhotography, video and lens-based practiceImmunogenetics (incl. genetic immunology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 09, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.

Somedeb Ball, Farrukh T Awan, Ben K Tomlinson

|Apr 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.

Tamara K Moyo, Ashwin Kishtagari, Matthew T Villaume

|Jul 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Asmita Mishra, Roni Tamari, Amy E DeZern

|Jun 29, 2022
Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience.

Bhagirathbhai Dholaria, Nasima Mehraban, Brittney Baer

|Aug 17, 2021
Cytomegalovirus immunoglobulin G: passive transfer or prior infection?

Michael Byrne, Amelia A Langston, Garrett S Booth

|Jun 07, 2021
Isocitrate dehydrogenase inhibitor-driven differentiation may resemble secondary graft failure in post-allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia.

Adrianne Rasche, Emily F Mason, Stephen A Strickland

Pageof 2

Frequent Collaborators

2 joint publications

Bhagirathbhai Dholaria

2 joint publications

Stephen A Strickland

2 joint publications

P Brent Ferrell

2 joint publications

Michael R Savona